Achillion Pharma (ACHN) Reports Q3 Loss of $0.15
Tweet
Share
E-mail
Get Alerts ACHN Hot Sheet
Join SI Premium – FREE
Achillion Pharma (NASDAQ: ACHN) reported Q3 EPS of ($0.15), versus ($0.16) reported last year.
For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- RCM Technologies (RCMT) Tops Q2 EPS by 17c
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
